Confo Therapeutics
Confo Therapeutics is a clinical-stage biotechnology company focused on discovering novel medicines targeting G-protein coupled receptors (GPCRs). They utilize a proprietary platform employing conformation-specific ConfoBodies® to identify small molecules and antibodies with desired pharmacology, building a pipeline of product candidates for metabolic and endocrine diseases.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: €60M
Date: 26-Jul-2024
Investors: Ackermans & van Haaren (AvH), Driehaus Capital Management, Quest for Growth (QfG), BioGeneration Ventures (BGV), Capricorn Health-tech Fund (CHF), Fund+, MINTS (University of Michigan), Perceptive Advisors, Qbic, PMV, V-Bio Ventures, VIB, Wellington Partners
Markets: Biotechnology, Pharmaceuticals, Therapeutics
HQ: Zwijnaarde, Belgium, Belgium
Founded: 2015
Website: https://www.confotherapeutics.com/
LinkedIn: https://be.linkedin.com/company/confo-therapeutics
Crunchbase: https://www.crunchbase.com/organization/confo-therapeutics
Leave a Comment
Comments
No comments yet.